IR@PKUHSC  > 北京大学基础医学院  > 病原生物学系
学科主题基础医学
Chronic hepatitis B: treatment alert
Chang, Ting-Tsung; Zhang, Hui; Jia, Jidong; Leung, Nancy Wai-Yee; Guan, Richard; Jafri, S. M. Wasim; Lesmana, Laurentlus A.; Liaw, Yun-Fan; Locarnini, Stephen; Omata, Masao; Sollano, Jose D.; Suh, Dong Jin; Mahachai, Varocha; Phiet, Pham Hoang; Sarin, Shiv K.; Yao, Guangbi; Yoon, Seung Kew; ACT-HBV Asia-Pacific Steering
关键词ALT levels consensus statement HBeAg negative HBeAg positive HBV DNA levels treatment guidelines
刊名LIVER INTERNATIONAL
2006-12-01
DOI10.1111/j.1478-3231.2006.01374.x
suppl.2期:0页:47-58
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Gastroenterology & Hepatology
研究领域[WOS]Gastroenterology & Hepatology
关键词[WOS]ADEFOVIR DIPIVOXIL ; HEPATOCELLULAR-CARCINOMA ; VIRUS INFECTION ; LAMIVUDINE THERAPY ; UNITED-STATES ; LYMPHOBLASTOID INTERFERON ; PREEMPTIVE LAMIVUDINE ; CONSENSUS STATEMENT ; TREATMENT ALGORITHM ; POSITIVE PATIENTS
英文摘要

Chronic hepatitis B (CHB) is a serious global health concern, particularly in the Asia-Pacific region. New information on the clinical management of CHB is emerging rapidly, requiring that physicians be alerted to updated treatment recommendations. The ACT-HBV Asia-Pacific Steering Committee members, composed of experts in hepatitis B from throughout the Asia-Pacific region, reviewed and discussed new clinical data as reported in the literature or presented at recent international congresses, and recommended that physicians be alerted to updated treatment recommendations. Hepatitis B e antigen (HBeAg)-positive patients with HBV DNA levels of >= 20 000 IU/ml (>= 10(5) copies/ml) and elevated alanine aminotransferase levels should be considered for treatment. It is suggested that HBV DNA >= 2000 IU/ml (>= 10(4) copies/ml) is the more appropriate threshold for the treatment of HBeAg-negative patients. Lamivudine, adefovir dipivoxil, interferon alpha-2b, thymosin alpha-1, and, most recently, entecavir, and pegylated interferon alpha-2a are licensed for the management of CHB. The treatment recommendations from the 2005 Asian-Pacific Consensus Statement on the Management of Chronic Hepatitis B have been updated to incorporate these new therapeutic options. A summary of treatment recommendations for special patient populations is also included.

语种英语
WOS记录号WOS:000242602200007
引用统计
被引频次:1[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
版本出版稿
条目标识符http://ir.bjmu.edu.cn/handle/400002259/58485
专题北京大学基础医学院_病原生物学系
作者单位1.Univ Santo Tomas Hosp, Manila 100864, Philippines
2.Asan Med Ctr, Seoul 138376, South Korea
3.Univ Delhi, GB Pant Hosp, New Delhi 110002, India
4.Univ Tokyo, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138655, Japan
5.Natl Cheng Kung Univ Hosp, Dept Med, Tainan 70428, Taiwan
6.Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100083, Peoples R China
7.Aga Khan Univ, Karachi 3500, Pakistan
8.Univ Indonesia, Jakarta Dept Med, Jakarta 10350, Indonesia
9.Victorian Infect Dis Reference Lab, Melbourne, Vic 3051, Australia
10.Capital Univ Med Sci, Beijing Friendship Hosp, Liver Res Ctr, Beijing 100050, Peoples R China
11.Alice Ho Miu Ling Nethersole Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
12.Natl Univ Singapore Hosp, Mt Elizabeth Med Ctr, Singapore 228510, Singapore
13.Chang Gung Mem Hosp & Univ, Liver Res Unit, Taipei 105, Taiwan
14.Chulalongkorn Univ, GI Unit, Dept Med, Bangkok 10330, Thailand
15.Univ Med & Pharm, Dept Immunol & Physiopathol, Ho Chi Minh City, Vietnam
16.Catholic Univ Korea, Div Hepatogastroenterol, Div Internal Med, Kangnam St Marys Hosp, Seoul 137040, South Korea
17.Shanghai Jing An Qu Cent Hosp, Clin Immun Res Ctr, Shanghai 200040, Peoples R China
推荐引用方式
GB/T 7714
Chang, Ting-Tsung,Zhang, Hui,Jia, Jidong,et al. Chronic hepatitis B: treatment alert[J]. LIVER INTERNATIONAL,2006,suppl.2(0):47-58.
APA Chang, Ting-Tsung.,Zhang, Hui.,Jia, Jidong.,Leung, Nancy Wai-Yee.,Guan, Richard.,...&ACT-HBV Asia-Pacific Steering.(2006).Chronic hepatitis B: treatment alert.LIVER INTERNATIONAL,suppl.2(0),47-58.
MLA Chang, Ting-Tsung,et al."Chronic hepatitis B: treatment alert".LIVER INTERNATIONAL suppl.2.0(2006):47-58.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
Chronic hepatitis B (327KB)期刊论文出版稿开放获取CC BY-NC-SA浏览 请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Chang, Ting-Tsung]的文章
[Zhang, Hui]的文章
[Jia, Jidong]的文章
百度学术
百度学术中相似的文章
[Chang, Ting-Tsung]的文章
[Zhang, Hui]的文章
[Jia, Jidong]的文章
必应学术
必应学术中相似的文章
[Chang, Ting-Tsung]的文章
[Zhang, Hui]的文章
[Jia, Jidong]的文章
相关权益政策
暂无数据
收藏/分享
文件名: Chronic hepatitis B treatment alert.pdf
格式: Adobe PDF
此文件暂不支持浏览
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。